Special Issue "Marine Natural Products with Anti-Inflammatory Effects"
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 818
Special Issue Editor
Interests: biochemistry; cell biology; mechanism of the biological activity of natural and synthetic biologically active substances; inflammation; new drug discovery; molecular targets; oncology; apoptosis; neurodegenerative disorders; cytoprotection; cells of the immune system
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammation is the first reaction of the body's immune system to damage or injury, microbial invasion and immune responses. Acute inflammation is a protective reaction that usually subsides after a few days. However, in some diseases, the immune system mistakenly fights against the body's own cells, causing chronic inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel diseases, COPD, etc. These diseases can last for years or even a lifetime. Natural compounds of organisms of marine origin are known for their structural diversity and wide range of biological activities. Thus, they are a highly promising chemical resource for the discovery of active compounds that may serve as potential anti-inflammatory drugs.
This Special Issue aims to present research articles on the anti-inflammatory properties of marine natural compounds. We particularly welcome works on the isolation and determination of the structure of new compounds of marine origin that have anti-inflammatory activities and are based on the latest in vitro and in vivo models
Dr. Ekaterina S. Menchinskaya
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new drug discovery and development
- inflammation
- anti-inflammatory agents
- biologically active marine compounds
- reactive oxygen species (ROS)
- immune system
- non-steroidal anti-inflammatory drugs (NSAIDs)
- immunomodulation
- cytokines
